Cargando…

Key Difficulties Associated with Cancer Biology

Detalles Bibliográficos
Autores principales:	Fang, Xiaolan, Aragon-Ching, Jeanny, Cidon, Esther Una
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111570/ https://www.ncbi.nlm.nih.gov/pubmed/27891057 http://dx.doi.org/10.4137/CMO.S41271

Ejemplares similares

Assessment of real-world application of advanced prostate cancer management in Japan
por: Aragon-Ching, Jeanny B.
Publicado: (2022)

The Challenge of Metastatic Colorectal Cancer
por: Cidón, Esther Uña
Publicado: (2010)

Nutritional Status After Total Gastrectomy for Gastric Cancer
por: Cidon, Esther Una
Publicado: (2010)

Gastric cancer and the search for a good prognostic classification: a challenge
por: Cidón, Esther Uña
Publicado: (2010)

A Commentary on “Risk Factors for Renal Cell Cancer in a Japanese Population”
por: Cidon, Esther Uña
Publicado: (2009)

The path forward in prostate cancer therapeutics
por: Aragon-Ching, Jeanny B, et al.
Publicado: (2018)

Multidisciplinary treatment (MDT) perspectives in renal cell carcinoma
por: Aragon-Ching, Jeanny B., et al.
Publicado: (2023)

Financial toxicity differences between chemical versus surgical androgen deprivation therapy
por: Aragon-Ching, Jeanny B., et al.
Publicado: (2022)

New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future
por: Cidon, Esther Una
Publicado: (2017)

Systemic treatment of hepatocellular carcinoma: Past, present and future
por: Cidon, Esther Una
Publicado: (2017)

Vasoactive intestinal peptide secreting tumour: An overview
por: Una Cidon, Esther
Publicado: (2022)

Myalgia-arthralgia syndrome induced by docetaxel in oncology: the wolf disguised as a sheep
por: Cidon, Esther Una
Publicado: (2018)

Life after Breast Cancer: Dealing with Lymphoedema
por: Cidón, Esther Uña, et al.
Publicado: (2011)

The Evolution of Prostate Cancer Therapy: Targeting the Androgen Receptor
por: Aragon-Ching, Jeanny B.
Publicado: (2014)

The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2020)

Gastric Adenocarcinoma: Is Computed Tomography (CT) Useful in Preoperative Staging?
por: Cidón, Esther Uña, et al.
Publicado: (2009)

Use of early chemotherapy for hormone-sensitive prostate cancer: time for CHAARTED
por: Aragon-Ching, Jeanny B
Publicado: (2016)

The promising role of poly(ADP-ribose) polymerase inhibitors in prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2016)

Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2019)

ARASENS: making sense out of first-line metastatic hormone-sensitive prostate cancer treatment
por: Aragon-Ching, Jeanny B
Publicado: (2022)

Further analysis of PREVAIL: enzalutamide use in chemotherapy-naïve men with metastatic castration-resistant prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2014)

Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies
por: Cidon, E. Una
Publicado: (2016)

Vitamin D in prostate cancer
por: Trump, Donald L, et al.
Publicado: (2018)

Balancing efficacy and quality of life measurements among metastatic renal cell carcinoma (RCC) studies
por: Aragon-Ching, Jeanny B.
Publicado: (2021)

Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer
por: Rhea, Logan P, et al.
Publicado: (2021)

The difficulties in cancer treatment
por: Chakraborty, Sajib, et al.
Publicado: (2012)

Radium-223 for the treatment of castration-resistant prostate cancer
por: El-Amm, Joelle, et al.
Publicado: (2015)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2016)

The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2019)

Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?
por: Cidon, E. Una, et al.
Publicado: (2016)

Editorial: Radical cystectomy in bladder cancer patients
por: Koshkin, Vadim S., et al.
Publicado: (2022)

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Lohiya, Vipin, et al.
Publicado: (2016)

Role of chemotherapy in prostate cancer
por: Nader, Rita, et al.
Publicado: (2018)

Molecular Targeted Agents for Gastric Cancer: A Step Forward Towards Personalized Therapy
por: Cidon, Esther Una, et al.
Publicado: (2013)

Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer
por: Rhea, Logan P, et al.
Publicado: (2019)

Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives
por: El-Amm, Joelle, et al.
Publicado: (2017)

The Leave Difficulty
Publicado: (1913)

Difficulties in Practice
Publicado: (1869)

Difficulties of Diagnosis
Publicado: (1880)

Angiogenesis Inhibition in Prostate Cancer: Current Uses and Future Promises
por: Aragon-Ching, Jeanny B., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_l8c76n8k9u4v8827km134s1qbm